A new study has found that monitoring pain response levels during surgery with NOL – Nociception Level Index® technology can help reduce intraoperative opioid usage and postoperative pain up to 3 days after surgery. The study, titled ‘Effect of nociception level-directed analgesic management on opioid usage in robot-assisted laparoscopic radical prostatectomy: a single-center single-blinded randomized controlled trial (NOLDOR study) assessed the clinical utility of NOL guided opioid dosing.
Newsdesk
Follow Medasense’s accomplishments and news